Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis
Lee, Jae-Lyun, Desai, Chirag, Park, Se Hoon, Tsuchiya, Norihiko, Su, Po-Jung, Chan, Timothy Tim Wai, Gurney, Howard, Gao, Seasea, Wang, Jing, Sandner, Robin, di Pietro, Alessandra, Eto, Masatoshi
Published in Urologic oncology (01.05.2023)
Published in Urologic oncology (01.05.2023)
Get full text
Journal Article
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
Hawkes, Eliza A., Phillips, Tycel, Budde, Lihua Elizabeth, Santoro, Armando, Saba, Nakhle S., Roncolato, Fernando, Gregory, Gareth P., Verhoef, Gregor, Offner, Fritz, Quero, Cristina, Radford, John, Giannopoulos, Krzysztof, Stevens, Don, Thall, Aron, Huang, Bo, Laird, A. Douglas, Sandner, Robin, Ansell, Stephen M.
Published in Targeted oncology (01.11.2021)
Published in Targeted oncology (01.11.2021)
Get full text
Journal Article